Back to search

Boston University

Design of adaptive multi-arm multi-stage clinical trials

Abstract

dc:description.abstract

Two-arm group sequential designs have been widely used for over forty years, especially for studies with mortality endpoints. The natural generalization of such designs to trials with multiple treatment arms and a common control (MAMS designs) has, however, been implemented rarely. While the statistical methodology for this extension is clear, the main limitation has been an efficient way to perform the computations. Past efforts were hampered by algorithms that were computationally explosive. With the increasing interest in adaptive designs, platform designs, and other innovative designs that involve multiple comparisons over multiple stages, the importance of MAMS designs is growing rapidly. This dissertation proposes a group sequential approach to design MAMS trial where the test statistic is the maximum of the cumulative score statistics for each pair-wise comparison, and is evaluated at each analysis time point with respect to efficacy and futility stopping boundaries while maintaining strong control of the family wise error rate (FWER). In this dissertation we start with a break-through algorithm that will enable us to compute MAMS boundaries rapidly. This algorithm will make MAMS design a practical reality. For designs with efficacy-only boundaries, the computational effort increases linearly with number of arms and number of stages. For designs with both efficacy and futility boundaries the computational effort doubles with successive increases in number of stages. Previous attempts to obtain MAMS boundaries were confined to smaller problems because their computational effort grew exponentially with number of arms and number of stages. We will next extend our proposed group sequential MAMS design to permit adaptive changes such as dropping treatment arms and increasing the sample size at each interim analysis time point. In order to control the FWER in the presence of these adaptations the early stopping boundaries must be re-computed by invoking the conditional error rate principle and the closed testing principle. This adaptive MAMS design is immensely useful in phase~2 and phase~3 settings. An alternative to the group sequential approach for MAMS design is the p-value combination approach. This approach has been in place for the last fifteen years.This alternative MAMS approach is based on combining independent p-values from the incremental data of each stage. Strong control of the FWER for this alternative approach is achieved by closed testing. We will compare the operating characteristics of the two approaches both analytically and empirically via simulation. In this dissertation we will demonstrate that the MAMS group sequential approach dominates the traditional p-value combination approach in terms of statistical power.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biostatistics
Grantor
Boston University
Year dc:date.issued
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ghosh, Pranab Kumar
Advisor dc:contributor.advisor
  • D'Agostino, Ralph B.

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/27546

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ghosh, Pranab Kumar. Design of adaptive multi-arm multi-stage clinical trials. doctoral thesis, Boston University, 2018. https://hdl.handle.net/2144/27546